Artivion, Inc. Stock

Equities

AORT

US2289031005

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
20.03 USD -0.89% Intraday chart for Artivion, Inc. -2.10% +12.02%
Sales 2024 * 388M Sales 2025 * 427M Capitalization 835M
Net income 2024 * -10M Net income 2025 * 7M EV / Sales 2024 * 2.15 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.96 x
P/E ratio 2024 *
-68.1 x
P/E ratio 2025 *
164 x
Employees 1,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 85.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.89%
1 week-2.10%
Current month-5.34%
1 month-1.77%
3 months+9.81%
6 months+57.34%
Current year+12.02%
More quotes
1 week
19.53
Extreme 19.525
20.64
1 month
19.53
Extreme 19.525
21.90
Current year
16.48
Extreme 16.4842
21.90
1 year
12.16
Extreme 12.1582
21.90
3 years
9.64
Extreme 9.64
32.34
5 years
9.64
Extreme 9.64
33.00
10 years
8.40
Extreme 8.4
36.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 14-09-01
Director of Finance/CFO 51 Dec. 03
Chief Operating Officer 42 23-05-31
Members of the board TitleAgeSince
Director/Board Member 59 12-04-30
Director/Board Member 69 03-11-30
Director/Board Member 64 03-11-30
More insiders
Date Price Change Volume
24-04-19 20.03 -0.89% 128,356
24-04-18 20.21 +1.35% 214,213
24-04-17 19.94 -1.82% 150,611
24-04-16 20.31 -0.20% 109,572
24-04-15 20.35 -0.54% 150,448

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
20.21 USD
Average target price
25.15 USD
Spread / Average Target
+24.44%
Consensus